Circadian Character of Food Compulsions and Impulses Control Disorders in Parkinsonian Patients With and Without Resting Leg Syndrome
RLS nighfood
2 other identifiers
interventional
55
1 country
1
Brief Summary
Investigator have recently shown that Parkinson disease patients' with restless leg Syndrome have more frequent impulse control behavior in particular compulsive feeding that patients without Restless Leg Syndrome (RLS). Investigator hypothesized that presence of RLS in parkinsonian patients could be a risk factor for the emergence of TCI or associated behaviors, occurring preferentially at night. The main objective of this study is to evaluate in patients with idiopathic Parkinson's disease (IPD) the effect of the presence of a RLS on the evening compulsive eating behavior by studying the circadian modulation of food intake of patients with RLS and impulse control disorders. For this investigator conduct a prospective study, with 2 groups of Parkinson disease patients (with and without restless leg syndrome), to which investigator have to fill an agenda to know the schedule of the behaviors during the day and the night.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable parkinson-disease
Started Jan 2019
Longer than P75 for not_applicable parkinson-disease
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 21, 2019
CompletedFirst Submitted
Initial submission to the registry
January 24, 2019
CompletedFirst Posted
Study publicly available on registry
January 28, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 16, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
June 22, 2023
CompletedJuly 10, 2023
July 1, 2023
3.4 years
January 24, 2019
July 7, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The percentage of daily night food intake measured at baseline + 15 day using the diary.
at baseline + 15 day
Secondary Outcomes (6)
Percentage of night behavior for the other impulse control disorders , measured at baseline + 15 day using the diary
at baseline + 15 day
Percentage of patients with compulsive food intake measured at baseline + 15 day
at baseline + 15 day
Percentage of patients with others impulse control disorders or other associated behavior measured at baseline + 15 day
at baseline + 15 day
Percentage of patients with the night eating syndrome using the Night Eating Questionnaire measured at baseline + 15 days
at baseline + 15 day
Percentage of patients with Sleep related eating disorders using the International classification of sleep disorders-third edition criteria measured at baseline + 15 days
at baseline + 15 day
- +1 more secondary outcomes
Study Arms (2)
RLS-
EXPERIMENTALpatients with Parkinson disease without RLS
RLS+
EXPERIMENTALpatients with Parkinson disease with RLS
Interventions
During 7 days, at home, patients must report in their diary all their impulse control disorders especially their compulsive eating disorders. They will detailed each food intake and drink intake and the time.
Eligibility Criteria
You may qualify if:
- Men or women, 18 to 80 years
- Patients with a Parkinson disease (PD) with UKPDSBB criteria
- Social security affiliation
- Acceptance of the protocol and signature of a written consent
- RLS group: Patients with IRLSSG criteria of RLS, with a frequency of RLS ≥ 2 times per week Group without RLS: Patients without IRLSSG criteria of RLS
You may not qualify if:
- Patients with an other neurological disease than Parkinson's disease
- Patients with secondary RLS (other than Parkinson's disease)
- Patients with psychiatric diseases
- Patients with cognitive disorder (MoCA \<21)
- Patients with body mass index \<16.5 or \>30
- Patients with sleep-waking rhythm disorders (such as night work…)
- Patients under trusteeship or guardianship or safeguarding of justice
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Clermont-Ferrand
Clermont-Ferrand, 63003, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ana MARQUES
University Hospital, Clermont-Ferrand
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- NONE
- Masking Details
- no masking
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 24, 2019
First Posted
January 28, 2019
Study Start
January 21, 2019
Primary Completion
June 16, 2022
Study Completion
June 22, 2023
Last Updated
July 10, 2023
Record last verified: 2023-07